Assembly Biosciences
Jeanette Bjorkquist is an experienced finance professional currently serving as Treasurer and Executive Director of Accounting & Treasury at Assembly Biosciences, Inc. since April 2019. Jeanette has held multiple senior roles at the company, including Principal Accounting Officer and Senior Director of Accounting & Treasury. Prior to this, Jeanette worked at OUM & Co. LLP from September 2010 to April 2019 as an Audit Manager, providing assurance and consulting services to various industries, including life sciences, real estate, and technology. Jeanette holds a Master of Business Administration in Accounting from Niagara University Graduate School and a Bachelor of Business Administration, Summa Cum Laude in Accounting from Niagara University, along with two associate degrees from Skyline College.
Assembly Biosciences
9 followers
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the development of a new class of potent, oral core inhibitor drug candidates, Assembly Bio’s approach aims to break the complex viral replication cycle of HBV to free patients from a lifetime of therapy. Assembly Bio’s strategy toward cure includes a leading portfolio of more potent, next-generation core inhibitors, proof-of-concept combination studies and a research program focused on the discovery of novel HBV targets.